Pancreatic Cancer Research

ResearcherFred Hutch Cancer CenterActive in the last 2 years

Ann McNeill Killary

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9250-0832; OpenAlex author ID A5056275367; NIH RePORTER profile ID 1859444. Sources: OpenAlex.

Their work

Papers
14 (first author 0, last author 3)
Trials
0
Grants
2
Labs led
1
Collaborators
57
Papers, trials and grants by year

2011: 2 papers · 2012: 1 paper · 2013: none · 2014: 2 papers · 2015: 1 paper, 1 grant · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 2 papers · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 2 papers, 1 grant

Papers 14

  1. Machine learning-based multimodal biomarkers enable accurate diagnosis and early detection of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41598-025-29548-4↗
  2. Pancreatic Cancer Detection Consortium Biomarker Bakeoff: A Phase II Blinded Biomarker Validation and Panel Discovery Study. Co-author DOI 10.1158/1078-0432.ccr-25-4061↗
  3. Blood-Based microRNA Biomarker Signature of Early-Stage Pancreatic Ductal Adenocarcinoma With Lead-Time Trajectory in Prediagnostic Samples. Co-author DOI 10.1016/j.gastha.2024.08.002↗
  4. Blood-based Migration Signature Biomarker Panel Discriminates Early Stage New Onset Diabetes related Pancreatic Ductal Adenocarcinoma from Type 2 Diabetes. Last author DOI 10.1016/j.cca.2023.117567↗
  5. Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic Cancer. Co-author DOI 10.1158/1940-6207.capr-20-0303↗
  6. Hyperpolarized Magnetic Resonance and Artificial Intelligence: Frontiers of Imaging in Pancreatic Cancer. Co-author DOI 10.2196/26601↗
  7. A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer. Last author DOI 10.1093/jnci/djw341↗
  8. Identification of genetic variants predictive of early onset pancreatic cancer through a population science analysis of functional genomic datasets. Co-author DOI 10.18632/oncotarget.10924↗
  9. Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specimens. Co-author DOI 10.1371/journal.pone.0139049↗
  10. Putative tumor suppressor gene SEL1L was downregulated by aberrantly upregulated hsa-mir-155 in human pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/mc.22023↗
  11. Circulating microRNAs in Pancreatic Juice as Candidate Biomarkers of Pancreatic Cancer. Co-author DOI 10.7150/jca.10094↗
  12. A single-nucleotide polymorphism in tumor suppressor gene SEL1L as a predictive and prognostic marker for pancreatic ductal adenocarcinoma in Caucasians. Co-author DOI 10.1002/mc.20808↗
  13. Susceptibility locus for lung cancer at 15q25.1 is not associated with risk of pancreatic cancer. Co-author DOI 10.1097/mpa.0b013e318219dafe↗
  14. A migration signature and plasma biomarker panel for pancreatic adenocarcinoma. Last author DOI 10.1158/1940-6207.capr-10-0025↗

Grants 2

  1. Circulating Biomarkers and Imaging for Early Detection of Pancreatic Cancer U01CA214263↗
  2. Biomarkers for the Early Detection of Pancreatic Cancer U01CA111302↗

Closest collaborators

The 25 strongest of 57 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Subrata Sen · 14 shared papers, 2 shared grants, 2011–2026 · strength 2.52
  2. Eugene Jon Koay · 2 shared papers, 1 shared grant, 2024–2026 · strength 1.41
  3. Seetharaman Balasenthil · 7 shared papers, 2011–2026 · strength 0.93
  4. Anirban Maitra · 5 shared papers, 2021–2026 · strength 0.80
  5. Suyu Liu · 5 shared papers, 2017–2026 · strength 0.75
  6. Randall E. Brand · 6 shared papers, 2015–2026 · strength 0.67
  7. Marsha L. Frazier · 8 shared papers, 1 shared grant, 2011–2017 · strength 0.50
  8. Ye Hu · 2 shared papers, 2024–2026 · strength 0.41
  9. Warapen Treekitkarnmongkol · 2 shared papers, 2024–2026 · strength 0.41
  10. Paul D. Lampe · 2 shared papers, 2024–2026 · strength 0.41
  11. Sudhir Srivastava · 3 shared papers, 2015–2026 · strength 0.32
  12. Michael Anthony Hollingsworth · 2 shared papers, 2015–2026 · strength 0.26
  13. Tsung-Hung Yao · 1 shared paper, 2026 · strength 0.24
  14. Nagireddy Putluri · 1 shared paper, 2026 · strength 0.24
  15. Suprateek Kundu · 1 shared paper, 2026 · strength 0.24
  16. Lynette M. Smith · 1 shared paper, 2026 · strength 0.23
  17. Masataka Hayashi · 1 shared paper, 2026 · strength 0.23
  18. Brianna M. Krusen · 1 shared paper, 2026 · strength 0.23
  19. Ann L. Oberg · 1 shared paper, 2026 · strength 0.23
  20. Michael Goggins · 1 shared paper, 2026 · strength 0.23
  21. Brian Matthew Wolpin · 1 shared paper, 2026 · strength 0.23
  22. Surinder K. Batra · 1 shared paper, 2026 · strength 0.23
  23. Shounak Majumder · 1 shared paper, 2026 · strength 0.23
  24. Maneesh Jain · 1 shared paper, 2026 · strength 0.23
  25. Kenneth S. Zaret · 1 shared paper, 2026 · strength 0.23

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.